These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

713 related items for PubMed ID: 19347033

  • 1. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
    Ogihara T, Saruta T, Rakugi H, Fujimoto A, Ueshima K, Yasuno S, Oba K, Takeda K, Higaki J, Nakao K, CASE-J trial Group.
    Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
    [Abstract] [Full Text] [Related]

  • 2. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C, Vezali E, Tsiachris D, Dimitriadis K, Taxiarchou E, Chatzis D, Thomopoulos C, Syrseloudis D, Stefanadi E, Mihas C, Katsi V, Papademetriou V, Stefanadis C.
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.
    Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, Wada T.
    Hypertens Res; 2009 Dec; 32(12):1123-9. PubMed ID: 19816503
    [Abstract] [Full Text] [Related]

  • 5. Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimamoto K, Fujita T, Ito S, Naritomi H, Ogihara T, Shimada K, Tanaka H, Yoshiike N, J-HEALTH Study Committees.
    Hypertens Res; 2008 Mar; 31(3):469-78. PubMed ID: 18497466
    [Abstract] [Full Text] [Related]

  • 6. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimada K, Fujita T, Ito S, Naritomi H, Ogihara T, Shimamoto K, Tanaka H, Yoshiike N.
    Hypertens Res; 2008 Oct; 31(10):1903-11. PubMed ID: 19015598
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
    Fagard RH, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA.
    J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex).
    Ogihara T, Ueshima K, Nakao K, Fukiyama K, Oba K, Yasuno S, Fujimoto A, Sato T, Matsuoka H, Saruta T, CASE-J Ex Study Group.
    Hypertens Res; 2011 Dec; 34(12):1295-301. PubMed ID: 21833000
    [Abstract] [Full Text] [Related]

  • 10. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Dec; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 11. Effect of antihypertensive treatment on cardiovascular events in elderly hypertensive patients: Japan's Benidipine Research on Antihypertensive Effects in the Elderly (J-BRAVE).
    Saito I, Suzuki H, Kageyama S, Saruta T.
    Clin Exp Hypertens; 2011 Dec; 33(2):133-40. PubMed ID: 21269056
    [Abstract] [Full Text] [Related]

  • 12. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population.
    Cardio-Sis Study Group.
    J Hum Hypertens; 2008 Apr; 22(4):243-51. PubMed ID: 18046432
    [Abstract] [Full Text] [Related]

  • 13. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    Circulation; 2006 Mar 28; 113(12):1588-96. PubMed ID: 16534012
    [Abstract] [Full Text] [Related]

  • 14. Blood pressure variability as well as blood pressure level is important for left ventricular hypertrophy and brachial-ankle pulse wave velocity in hypertensives.
    Ozawa M, Tamura K, Okano Y, Matsushita K, Ikeya Y, Masuda S, Wakui H, Dejima T, Shigenaga A, Azuma K, Ishigami T, Toya Y, Ishikawa T, Umemura S.
    Clin Exp Hypertens; 2009 Nov 28; 31(8):669-79. PubMed ID: 20001459
    [Abstract] [Full Text] [Related]

  • 15. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
    Fagard RH, Staessen JA, Thijs L, Celis H, Bulpitt CJ, de Leeuw PW, Leonetti G, Tuomilehto J, Yodfat Y.
    Arch Intern Med; 2007 Sep 24; 167(17):1884-91. PubMed ID: 17893310
    [Abstract] [Full Text] [Related]

  • 16. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K.
    Hypertens Res; 2009 Jul 24; 32(7):575-80. PubMed ID: 19444280
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P, Woestenburg A, Brié H, Vancayzeele S, MacDonald K, Denhaerynck K, Lee C, Hermans C, Abraham I.
    Ann Pharmacother; 2009 May 24; 43(5):849-61. PubMed ID: 19351876
    [Abstract] [Full Text] [Related]

  • 18. Blood pressure as a predictor of cardiovascular events in the elderly: the William Hale Research Program.
    Masley SC, Phillips SE, Schocken DD.
    J Hum Hypertens; 2006 Jun 24; 20(6):392-7. PubMed ID: 16543911
    [Abstract] [Full Text] [Related]

  • 19. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb 24; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 20. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM, Schmieder RE.
    Am J Hypertens; 2008 May 24; 21(5):500-8. PubMed ID: 18437140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.